635 related articles for article (PubMed ID: 8757629)
21. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
Samoszuk M; Corwin M; Hazen SL
Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
[TBL] [Abstract][Full Text] [Related]
22. [Effect of eosinophil major basic protein on histamine release from nasal epithelial mast cells].
Xiao S; Okuda M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 32(4):201-4. PubMed ID: 10743163
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
24. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
[TBL] [Abstract][Full Text] [Related]
25. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch.
Minnicozzi M; Durán WN; Gleich GJ; Egan RW
J Immunol; 1994 Sep; 153(6):2664-70. PubMed ID: 7521368
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.
Motojima S; Frigas E; Loegering DA; Gleich GJ
Am Rev Respir Dis; 1989 Mar; 139(3):801-5. PubMed ID: 2923379
[TBL] [Abstract][Full Text] [Related]
28. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.
Peters MS; Rodriguez M; Gleich GJ
Lab Invest; 1986 Jun; 54(6):656-62. PubMed ID: 3520144
[TBL] [Abstract][Full Text] [Related]
29. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ
J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865
[TBL] [Abstract][Full Text] [Related]
31. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
32. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
Hamann KJ; Barker RL; Loegering DA; Gleich GJ
J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
[TBL] [Abstract][Full Text] [Related]
33. In vitro diagnosis of chronic nasal inflammation.
Kramer MF; Burow G; Pfrogner E; Rasp G
Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
35. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
36. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes.
Vliagoftis H; Lacy P; Luy B; Adamko D; Hollenberg M; Befus D; Moqbel R
Int Arch Allergy Immunol; 2004 Nov; 135(3):196-204. PubMed ID: 15467372
[TBL] [Abstract][Full Text] [Related]
37. [Hypereosinophilias of the blood. I. Eosinophilic granulocytes].
Lovisetto P; Manachino D; Biarese V; Marchi L; Andrione P
Minerva Med; 1985 May; 76(21):975-83. PubMed ID: 3923403
[TBL] [Abstract][Full Text] [Related]
38. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
Winqvist I; Olofsson T; Olsson I
Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
[TBL] [Abstract][Full Text] [Related]
40. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]